GlassScriptPhysician profile
Monique J Carasso
NPI 1992835581
$2,818.00
in general payments reported to CMS, 2019-2025
11 companies · $1,124 in 2025
The $1,124 reported for 2025 was more than what 89% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $285 · 2022: $298 · 2023: $374 · 2024: $737 · 2025: $1,124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,001.67 | 2021-2025 | Xifaxan, Trulance |
| Gilead Sciences, INC. | $489.00 | 2022-2025 | |
| Madrigal Pharmaceuticals | $334.01 | 2024-2025 | Rezdiffra, Resmetirom |
| Intercept Pharmaceuticals, INC. | $259.40 | 2023-2025 | Ocaliva |
| Ipsen Biopharmaceuticals, INC | $220.80 | 2024-2025 | Iqirvo |
| Janssen Biotech, INC. | $171.89 | 2021-2023 | Symtuza |
| Janssen Products, LP | $129.94 | 2021 | |
| Orphalan INC | $128.09 | 2024-2025 | Cuvrior |
| Abbvie INC. | $33.39 | 2025 | |
| Mirum Pharmaceuticals, INC. | $27.86 | 2025 | Livmarli |
| Intra-Sana Laboratories | $21.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Carasso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.